ZNF202

Summary

ZNF202 (zinc finger protein 202, HGNC:12994) is a protein-coding gene on chromosome 11q23.3, encoding Zinc finger protein 202 (O95125). Transcriptional repressor that binds to elements found predominantly in genes that participate in lipid metabolism.

Enables DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in chromosome; nuclear body; and nucleolus.

Source: NCBI Gene 7753 — RefSeq curated summary.

At a glance

• GWAS associations: 2
• Clinical variants (ClinVar): 69 total
• MANE Select transcript: NM_003455

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:12994
Approved symbol	ZNF202
Name	zinc finger protein 202
Location	11q23.3
Locus type	gene with protein product
Status	Approved
Aliases	ZKSCAN10, ZSCAN42
Ensembl gene	ENSG00000166261
Ensembl biotype	protein_coding
OMIM	603430
Entrez	7753

Gene structure

Transcript identifiers

Ensembl transcripts: 37 — 34 protein_coding, 3 protein_coding_CDS_not_defined

ENST00000336139, ENST00000525391, ENST00000526252, ENST00000528306, ENST00000529250, ENST00000529691, ENST00000530393, ENST00000530944, ENST00000533463, ENST00000880206, ENST00000880207, ENST00000880208, ENST00000880209, ENST00000880210, ENST00000880211, ENST00000925721, ENST00000925722, ENST00000925723, ENST00000925724, ENST00000925725, ENST00000925726, ENST00000925727, ENST00000925728, ENST00000925729, ENST00000925730, ENST00000925731, ENST00000925732, ENST00000925733, ENST00000925734, ENST00000925735, ENST00000925736, ENST00000925737, ENST00000925738, ENST00000925739, ENST00000965489, ENST00000965490, ENST00000965491

RefSeq mRNA: 4 — MANE Select: NM_003455 NM_001301779, NM_001301780, NM_001301819, NM_003455

CCDS: CCDS8443

Canonical transcript exons

ENST00000530393 — 9 exons

Exon	Start	End
ENSE00001101510	123727476	123727595
ENSE00001101512	123728133	123728262
ENSE00001101515	123729126	123729214
ENSE00001101523	123729615	123729825
ENSE00001378603	123730487	123730985
ENSE00001424554	123740417	123740536
ENSE00001425163	123740117	123740192
ENSE00002146557	123741549	123741660
ENSE00003842847	123723914	123726991

Expression profiles

Bgee: expression breadth ubiquitous, 217 present calls, max score 87.02.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.3392 / max 75.1101, expressed in 1696 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter ID	TPM avg	Samples expressed
122922	5.3392	1696

Top tissues by expression

276 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
secondary oocyte	CL:0000655	87.02	gold quality
oocyte	CL:0000023	86.63	gold quality
body of pancreas	UBERON:0001150	83.98	gold quality
granulocyte	CL:0000094	83.20	gold quality
cortical plate	UBERON:0005343	83.03	gold quality
primordial germ cell in gonad	CL:0000670 ∩ UBERON:0000991	82.52	gold quality
right ovary	UBERON:0002118	81.92	gold quality
ventricular zone	UBERON:0003053	81.74	gold quality
left ovary	UBERON:0002119	81.63	gold quality
left uterine tube	UBERON:0001303	81.09	gold quality
pancreas	UBERON:0001264	81.07	gold quality
body of uterus	UBERON:0009853	81.02	gold quality
rectum	UBERON:0001052	80.97	gold quality
ganglionic eminence	UBERON:0004023	80.72	gold quality
right testis	UBERON:0004534	80.70	gold quality
ovary	UBERON:0000992	80.56	gold quality
left testis	UBERON:0004533	80.36	gold quality
male germ line stem cell (sensu Vertebrata) in testis	CL:0000089 ∩ UBERON:0000473	79.93	gold quality
monocyte	CL:0000576	79.88	gold quality
testis	UBERON:0000473	79.75	gold quality
right lobe of thyroid gland	UBERON:0001119	79.62	gold quality
gastrocnemius	UBERON:0001388	79.59	gold quality
leukocyte	CL:0000738	79.58	gold quality
mononuclear cell	CL:0000842	79.58	gold quality
endocervix	UBERON:0000458	79.49	gold quality
muscle of leg	UBERON:0001383	79.15	gold quality
transverse colon	UBERON:0001157	79.14	gold quality
spleen	UBERON:0002106	79.05	gold quality
stromal cell of endometrium	CL:0002255	78.96	gold quality
islet of Langerhans	UBERON:0000006	78.95	gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

Experiment	Marker?	Max mean expression
E-ANND-3	no	3.56

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

7 targets.

Target	Regulation
ABCA1	Repression
ABCG1	Repression
AMACR	Unknown
APOA1	Repression
APOE
FSHR	Repression
POMGNT1	Repression

Upstream regulators (CollecTRI, top): SCAND1, SOX17

miRNA regulators (miRDB)

70 targeting ZNF202, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-188-3P	100.00	68.76	1240
HSA-MIR-4500	99.99	72.72	2367
HSA-MIR-5696	99.98	72.36	4487
HSA-LET-7A-5P	99.98	72.29	1790
HSA-LET-7B-5P	99.98	72.31	1790
HSA-LET-7C-5P	99.98	72.29	1790
HSA-LET-7E-5P	99.98	72.29	1790
HSA-LET-7F-5P	99.98	72.56	1784
HSA-LET-7G-5P	99.98	72.37	1784
HSA-LET-7I-5P	99.98	72.37	1788
HSA-MIR-98-5P	99.98	72.33	1787
HSA-MIR-651-3P	99.94	73.48	5177
HSA-MIR-106A-5P	99.90	73.94	2683
HSA-MIR-3686	99.90	70.53	2432
HSA-MIR-17-5P	99.89	73.83	2665
HSA-MIR-106B-5P	99.88	74.72	2795
HSA-MIR-20A-5P	99.88	74.76	2769
HSA-MIR-20B-5P	99.88	74.01	2621
HSA-MIR-519D-3P	99.88	73.97	2607
HSA-MIR-93-5P	99.88	73.98	2606
HSA-MIR-526B-3P	99.88	74.06	2587
HSA-MIR-6505-5P	99.73	69.25	1595
HSA-MIR-4729	99.69	72.18	4233
HSA-MIR-3660	99.68	67.33	1149
HSA-MIR-4526	99.68	67.07	1136
HSA-MIR-6516-3P	99.65	68.57	1238
HSA-MIR-586	99.65	70.40	2051
HSA-MIR-5700	99.64	69.88	2280
HSA-MIR-587	99.64	70.86	2611
HSA-MIR-651-5P	99.64	68.49	1104

Literature-anchored findings (GeneRIF, showing 4)

• This is the first study to suggest that ZNF202 could be a new candidate gene for ischemic heart disease and myocardial infarction in the general population. (PMID:16289551)
• findings show that genetic variation in ZNF202 is common in the general population. However, SNPs in the protein-coding region of ZNF202 do not make a major contribution to HDL cholesterol levels. (PMID:16467280)
• SOX17-Chromatin immunoprecipitation identified zinc finger protein 202 (Zfp202) as a direct target of SOX17 during endoderm differentiation of F9 embryonal carcinoma cells. (PMID:18523156)
• Homozygosity for a common functional promoter variant in ZNF202 predicts severe atherosclerosis and an increased risk of IHD. (PMID:18652945)

Cross-species orthologs

11 orthologs

Organism	Symbol	Gene ID
danio_rerio	plagx	ENSDARG00000036855
danio_rerio	ovol1a	ENSDARG00000076472
danio_rerio	plagl2	ENSDARG00000076657
danio_rerio	ovol1b	ENSDARG00000078256
mus_musculus	Zfp202	ENSMUSG00000025602
rattus_norvegicus	Zfp202	ENSRNOG00000058932
drosophila_melanogaster	hb	FBGN0001180
drosophila_melanogaster	CG12391	FBGN0033581
caenorhabditis_elegans		WBGENE00001824
caenorhabditis_elegans		WBGENE00003033
caenorhabditis_elegans		WBGENE00012385

Paralogs (29): ZNF446 (ENSG00000083838), REST (ENSG00000084093), ZNF174 (ENSG00000103343), OVOL3 (ENSG00000105261), PLAGL1 (ENSG00000118495), ZSCAN18 (ENSG00000121413), ZNF576 (ENSG00000124444), OVOL2 (ENSG00000125850), PLAGL2 (ENSG00000126003), ZSCAN5A (ENSG00000131848), ZSCAN29 (ENSG00000140265), ZSCAN32 (ENSG00000140987), ZSCAN1 (ENSG00000152467), ZNF18 (ENSG00000154957), ZKSCAN2 (ENSG00000155592), ZNF496 (ENSG00000162714), ZNF641 (ENSG00000167528), ZNF444 (ENSG00000167685), SCAND1 (ENSG00000171222), ZNF274 (ENSG00000171606), ZNF131 (ENSG00000172262), OVOL1 (ENSG00000172818), ZNF518A (ENSG00000177853), ZNF518B (ENSG00000178163), PLAG1 (ENSG00000181690), ZSCAN5B (ENSG00000197213), ZNF770 (ENSG00000198146), PEG3 (ENSG00000198300), ZSCAN5C (ENSG00000204532)

Protein

Protein identifiers

Zinc finger protein 202 — O95125 (reviewed: O95125)

Alternative names: Zinc finger protein with KRAB and SCAN domains 10

All UniProt accessions (4): A0A1D5RMT9, E9PJL4, E9PM99, O95125

UniProt curated annotations — full annotation on UniProt →

Function. Transcriptional repressor that binds to elements found predominantly in genes that participate in lipid metabolism. Among its targets are structural components of lipoprotein particles (apolipoproteins AIV, CIII, and E), enzymes involved in lipid processing (lipoprotein lipase, lecithin cholesteryl ester transferase), transporters involved in lipid homeostasis (ABCA1, ABCG1), and several genes involved in processes related to energy metabolism and vascular disease.

Subunit / interactions. Interacts with SDP1.

Subcellular location. Nucleus.

Tissue specificity. Highly expressed in testis. Also expressed in breast carcinoma cell lines.

Isoforms (2)

UniProt ID	Names	Canonical?
O95125-1	Beta, 2	yes
O95125-2	Alpha, 1

RefSeq proteins (4): NP_001288708, NP_001288709, NP_001288748, NP_003446* (*=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR001909	KRAB	Domain
IPR003309	SCAN_dom	Domain
IPR013087	Znf_C2H2_type	Domain
IPR036051	KRAB_dom_sf	Homologous_superfamily
IPR036236	Znf_C2H2_sf	Homologous_superfamily
IPR038269	SCAN_sf	Homologous_superfamily

Pfam: PF00096, PF01352, PF02023

UniProt features (25 total): zinc finger region 8, cross-link 5, sequence conflict 3, domain 2, sequence variant 2, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-O95125-F1	59.20	0.05

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (6): 466, 22, 454, 460, 507, 521

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

ID	Pathway
R-HSA-212436	Generic Transcription Pathway

MSigDB gene sets: 138 (showing top): BROWNE_HCMV_INFECTION_4HR_UP, MORF_BRCA1, MORF_RAD51L3, MORF_CTSB, BLALOCK_ALZHEIMERS_DISEASE_UP, MORF_IL4, MORF_PRKCA, GOBP_LIPID_METABOLIC_PROCESS, AFP1_Q6, AACTTT_UNKNOWN, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, MORF_ATF2, MORF_PPP2R5B, GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, BROWNE_HCMV_INFECTION_14HR_UP

GO Biological Process (5): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357), lipid metabolic process (GO:0006629), regulation of DNA-templated transcription (GO:0006355), negative regulation of DNA-templated transcription (GO:0045892)

GO Molecular Function (9): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515), sequence-specific DNA binding (GO:0043565), metal ion binding (GO:0046872)

GO Cellular Component (4): chromosome (GO:0005694), nucleolus (GO:0005730), nuclear body (GO:0016604), nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

Category	Pathways
RNA Polymerase II Transcription	1

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
regulation of DNA-templated transcription	3
RNA polymerase II transcription regulatory region sequence-specific DNA binding	3
intracellular membraneless organelle	3
regulation of transcription by RNA polymerase II	2
transcription by RNA polymerase II	2
DNA-templated transcription	2
negative regulation of DNA-templated transcription	1
primary metabolic process	1
regulation of gene expression	1
regulation of RNA biosynthetic process	1
negative regulation of RNA biosynthetic process	1
cis-regulatory region sequence-specific DNA binding	1
chromatin	1
DNA-binding transcription factor activity	1
negative regulation of transcription by RNA polymerase II	1
DNA-binding transcription factor activity, RNA polymerase II-specific	1
DNA-binding transcription repressor activity	1
transition metal ion binding	1
nucleic acid binding	1
transcription cis-regulatory region binding	1
transcription regulator activity	1
binding	1
DNA binding	1
cation binding	1
nuclear lumen	1
nucleoplasm	1
intracellular membrane-bounded organelle	1

Protein interactions and networks

STRING

1008 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
ZNF202	MZF1	P28698	787
ZNF202	ZNF474	Q6S9Z5	660
ZNF202	ADTRP	Q96IZ2	618
ZNF202	ZNF534	Q76KX8	611
ZNF202	SCN3B	Q9NY72	504
ZNF202	STK32B	Q9NY57	500
ZNF202	TBX10	O75333	495
ZNF202	TRMO	Q9BU70	495
ZNF202	STX18	Q9P2W9	493
ZNF202	CRMP1	Q14194	492
ZNF202	EVC2	Q86UK5	492
ZNF202	HEMGN	Q9BXL5	491
ZNF202	WNT11	O96014	490
ZNF202	SATB2	Q9UPW6	476
ZNF202	LCAT	P04180	460

IntAct

77 interactions, top by confidence:

A	B	Type	Score
KRT40	ZNF202	psi-mi:“MI:0915”(physical association)	0.720
ZNF202	KRT40	psi-mi:“MI:0915”(physical association)	0.720
ZNF202	SCAND1	psi-mi:“MI:0915”(physical association)	0.660
ZNF202	SCAND1	psi-mi:“MI:0914”(association)	0.660
ZNF202	LMO4	psi-mi:“MI:0915”(physical association)	0.600
ZNF202		psi-mi:“MI:0915”(physical association)	0.560
ZNF202	MTIF3	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	CEP70	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	CARD10	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	MCC	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	ZNF837	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	SSX2IP	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	MEOX2	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	SEPHS1	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	NAA11	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	MAD2L1BP	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	NAA10	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	ZNF438	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	ZNF250	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	SCNM1	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	EAF1	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	ZNF835	psi-mi:“MI:0915”(physical association)	0.560
ZNF202	SNX2	psi-mi:“MI:0915”(physical association)	0.440

BioGRID (35): KRT40 (Two-hybrid), KRTAP10-3 (Two-hybrid), ZNF473 (Two-hybrid), ZMYM2 (Affinity Capture-MS), ZMYM3 (Affinity Capture-MS), SCAND1 (Affinity Capture-MS), TK1 (Affinity Capture-MS), ZNF202 (Affinity Capture-MS), RCOR3 (Affinity Capture-MS), ZNF202 (Two-hybrid), ZNF202 (Two-hybrid), ZNF202 (Two-hybrid), ZNF202 (Two-hybrid), ZNF202 (Two-hybrid), ZNF202 (Two-hybrid)

ESM2 similar proteins: A1YEQ3, A1YEV9, A1YFW6, A1YG26, A1YG48, A1YG60, A2T6W2, A2T712, A2T736, A2T7L7, A6QNZ0, O14978, O15535, O95125, P17022, P17029, P49910, P51815, P59923, Q07231, Q15776, Q16670, Q1LZ87, Q3MJ62, Q3URR7, Q4KLI1, Q4R8H9, Q53GI3, Q5R670, Q5R741, Q5RJ54, Q63HK3, Q642B9, Q6P9G9, Q810A1, Q86W11, Q8BGS3, Q8CF60, Q8NF99, Q92670

Diamond homologs: A1YEP8, A1YEQ3, A1YEV9, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A1YGK6, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F2, A2T7F4, A2T7L7, A2T812, A6QNZ0, A6QPT6, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17040, P28698, P49910, P51815, P59923

SIGNOR signaling

1 interactions.

A	Effect	B	Mechanism
ZNF202	“down-regulates quantity by repression”	POMGNT1	“transcriptional regulation”

Disease & clinical

Clinical variants and AI predictions

ClinVar

69 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	60
Likely benign	2
Benign	1

Top pathogenic / likely-pathogenic (0)

SpliceAI

1490 predictions. Top by Δscore:

Variant	Effect	Δscore
11:123728126:T:TA	donor_gain	1.0000
11:123728128:CTTA:C	donor_loss	1.0000
11:123728131:A:AC	donor_gain	1.0000
11:123728131:A:T	donor_loss	1.0000
11:123728132:C:CC	donor_gain	1.0000
11:123728132:C:CG	donor_loss	1.0000
11:123728132:CA:C	donor_gain	1.0000
11:123728132:CACAG:C	donor_gain	1.0000
11:123728162:T:TA	donor_gain	1.0000
11:123729213:CT:C	acceptor_gain	1.0000
11:123729215:C:CC	acceptor_gain	1.0000
11:123729610:C:A	donor_gain	1.0000
11:123729620:T:A	donor_gain	1.0000
11:123729644:T:TA	donor_gain	1.0000
11:123730542:T:TA	donor_gain	1.0000
11:123730986:C:CC	acceptor_gain	1.0000
11:123740432:T:TA	donor_gain	1.0000
11:123741547:A:AC	donor_gain	1.0000
11:123741548:C:CC	donor_gain	1.0000
11:123741548:CGG:C	donor_gain	1.0000
11:123741548:CGGCT:C	donor_gain	1.0000
11:123726989:CTC:C	acceptor_gain	0.9900
11:123726993:T:A	acceptor_loss	0.9900
11:123727003:G:GC	acceptor_gain	0.9900
11:123727470:CCTCA:C	donor_loss	0.9900
11:123727471:CTCA:C	donor_loss	0.9900
11:123727472:TCA:T	donor_loss	0.9900
11:123727473:CACC:C	donor_loss	0.9900
11:123727474:ACC:A	donor_loss	0.9900
11:123727475:C:G	donor_loss	0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000107100 (11:123731430 C>T), RS1000375346 (11:123725255 A>G), RS1000477735 (11:123731872 A>G), RS1000575230 (11:123741107 G>A), RS1000702029 (11:123731206 C>G,T), RS1000753845 (11:123742025 A>C), RS1000762377 (11:123724115 G>A), RS1000786123 (11:123737326 G>A), RS1001108285 (11:123737013 C>T), RS1001317758 (11:123728962 G>A), RS1001362147 (11:123741507 G>C), RS1001386055 (11:123730820 C>T), RS1001427092 (11:123742968 G>A), RS1001498516 (11:123736306 C>G,T), RS1001569461 (11:123735954 G>C)

Disease associations

OMIM: gene MIM:603430 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

Study	Trait	p-value
GCST000514_8	Response to antipsychotic therapy (extrapyramidal side effects)	4.000000e-07
GCST003802_5	Response to citalopram or escitalopram in depression	7.000000e-07

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

31 total (human), top 30 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Cyclosporine	increases expression	3
Valproic Acid	affects expression, decreases expression	2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide	decreases expression	1
TAK-243	decreases sumoylation	1
triphenyl phosphate	affects expression	1
sodium arsenite	decreases expression	1
ferrous chloride	decreases expression	1
perfluorooctane sulfonic acid	increases expression	1
CGP 52608	affects binding, increases reaction	1
ICG 001	increases expression	1
Sunitinib	increases expression	1
Leflunomide	increases expression	1
Acetaminophen	decreases expression	1
Adenine	decreases expression	1
Air Pollutants	increases abundance, increases expression	1
Benzo(a)pyrene	decreases methylation	1
Cisplatin	decreases expression	1
Colchicine	decreases expression	1
Diuron	decreases expression	1
Doxorubicin	decreases expression	1
Estradiol	increases expression	1
Ethyl Methanesulfonate	decreases expression	1
Etoposide	decreases expression	1
Formaldehyde	decreases expression	1
Herbicides	decreases expression	1
Methyl Methanesulfonate	decreases expression	1
Testosterone	decreases expression	1
Thiram	increases expression	1
Tobacco Smoke Pollution	increases expression	1
Mitomycin	decreases expression	1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_XW17	HEK293 eGFP-ZNF202	Transformed cell line	Female

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.